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Abstract
Background The purpose of this observational study was
to evaluate serum levels of 25-OH-D in patients scheduled
to undergo elective hip or knee arthroplasty. We hypoth-
esised that 25-OH-D level is an independent risk factor for
length of stay in orthopaedic patients after elective hip or
knee arthoplasty.
Materials and methods 25-OH-D levels were measured in
1083 patients admitted to an orthopaedic surgery depart-
ment to undergo elective hip or knee arthroplasty. Com-
parisons were performed using Chi square or Student’s
t test, followed by univariate and multiple linear regression
analysis examining the correlation between the length of
stay in the orthopaedic department and 25-OH-D level
while adjusting for possible confounders.
Results Overall, 86 % of patients had insufficient serum
levels of 25-OH-D, and over 60 % were vitamin D defi-
cient. The mean length of stay was 13.2 ± 8.3 days. In
patients with hypovitaminosis D, the length of stay was
significantly longer compared to patients with normal
serum 25-OH-D levels (15.6 ± 7.2 compared to
11.3 ± 7.9 days, P = 0.014). In univariate analyses, serum
25-OH-D level was inversely related to the length of stay in
our orthopaedic department compared to patients with
normal vitamin D levels (r = -0.16; P = 0.008). In
multivariate analyses, the length of stay remained signifi-
cantly associated with low 25-OH-D levels (P = 0.002),
indicating that low vitamin D levels increase the length of
stay.
Conclusions We found a high frequency of hypovita-
minosis D among orthopaedic patients scheduled to
undergo elective arthroplastic surgery. Low vitamin D
levels showed a significant inverse association to the length
of stay in our orthopaedic department. Patients with vita-
min D levels in the target range were hospitalised 4.3 days
less than patients with hypovitaminosis D.
Level 3 of evidence according to ‘‘The Oxford 2011 levels
of evidence’’.
Keywords Hypovitaminosis D  Vitamin D deficiency 
Length of stay  Orthopaedic patients
Introduction
Vitamin D deficiency is the most common nutritional
deficiency worldwide [1]. Variations in vitamin D defi-
ciency prevalence are dependent on the study population,
vitamin D fortification of foods, geographic location
(mainly latitude) and season [2, 3]. In previous studies, we
were able to show a widespread rate of vitamin D insuf-
ficiency among elderly orthopaedic patients (aged over
70 years) admitted to an orthopaedic university hospital
[4]. Extremely low vitamin D levels have been associated
with osteomalacia and impaired muscle function, both core
elements in the field of orthopaedic surgery. Good muscle
function and healthy bones are essential for fast
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rehabilitation and positive outcome after orthopaedic sur-
gery, as well as good physical function [4, 5].
Matthews et al. [6] reported an inverse relation between
length of hospital stay and vitamin D levels in surgical
patients admitted to the intensive care unit. With over 250
patients evaluated, the mean length of stay for patients with
severe vitamin D deficiency (\13 ng/mL) was 13.33 days,
compared to 5.17 days for patients with vitamin D levels
above 27 ng/mL. The length of stay of 253 patients of a
geriatric acute care unit was inversely associated with low
vitamin D levels. Helard et al. [7] reported that patients
with vitamin D levels below 50 nmol/L were hospitalised,
on average, 3 days more than patients with vitamin D
levels above 50 nmol/L.
We hypothesised that vitamin D level is an independent
risk factor for length of hospital stay in orthopaedic
patients receiving elective hip or knee arthroplasty.
Materials and methods
Between 1 January 2011 and 31 December 2012, the serum
25-OH-D levels (referred to as vitamin D) of 1083 patients
consecutively admitted to the orthopaedic department of
the university hospital in Mainz, Germany (50N) were
measured on admission. Patients were scheduled to receive
either elective knee or elective hip arthroplasty. Patients
scheduled to receive arthoplastic surgery due to a fracture
were excluded form the study. In general, blood was taken
on the day of admission. The mean age of the patients was
76 years (± 7.9 years) (Table 1).
Measurement of serum 25-OH-D was standardised; the
hospital laboratory used the ARCHITECT 25-OH Vita-
min D assay (Abbott GmbH & Co KG, Wiesbaden-
Delkenheim, Germany).
Hypovitaminosis D was defined as serum 25-OH-D
levels below 20 ng/mL according to the definition of the
World Health Organisation [8]. As yet there is no univer-
sally accepted classification of vitamin D levels, we defined
sufficient vitamin D status as a serum 25-OH-D level of
above 30 ng/mL. Vitamin D inadequacy was defined as a
serum 25-OH-D level of under 30 ng/mL, and was further
divided into vitamin D insufficiency (20–30 ng/mL) and
vitamin D deficiency (under 20 ng/mL) as described pre-
viously [9].
Patient demographic variables and background data
were evaluated by retrospective chart review, and were
used as potential confounders. Included variables were age,
sex, primary musculoskeletal diagnosis, BMI, comorbidi-
ties, oral medication (proton pump inhibitors and analget-
ics) and any vitamin D supplements taken before
admission.
The primary outcome measured in our study was
orthopaedic department length of stay. The length of stay
was calculated using the administrative registry of the
University Hospital of Mainz, Germany, by subtracting day
of admission from day of discharge.
Patients’ characteristics were summarised using either
means and standard deviations or frequencies and per-
centages. Firstly, patients were separated into two groups
based on vitamin D status (25-OH-D level above 20 ng/mL
or below 20 ng/mL).
Comparisons were performed using Chi square or Stu-
dent’s t test, followed by univariate and multiple linear
regression analyses examining the correlation between the
length of stay in the orthopaedic department (dependent
variable) and 25-OH-D level (independent variable) while
adjusting for possible confounders. Pearson correlation was
used to examine the association between the length of stay
in the orthopaedic department and 25-OH-D levels. A
P value\0.05 was considered to be significant. Statistical
analyses was performed with IBM SPSS statistics software
(ver. 21; IBM SPSS, Chicago, IL).
Results
A total of 1083 patients was enrolled in this study; 567
(52.4 %) of the study participants were women, 516
(47.5 %) were men. Mean age was 76 years, with a range
from 70 years to 97 years.
Overall, 86 % of the study population was vitamin D
insufficient and 63 % of patients were vitamin D deficient.
Of the 1083 vitamin D serum levels measured in this study,
only 8 % were in the target range of 30 to 60 ng/mL.
Serum vitamin D levels of all 1083 patients were normally
distributed, with a mean of 17.1 ng/mL; minimum and
maximum values ranged from 8 to 78.5 ng/mL, respec-
tively. The mean length of stay was 13.2 ± 8.3 days. We
found that the length of stay was longer in patients with
hypovitaminosis D compared to patients with normal
serum 25-OH-D levels (15.6 ± 7.2 compared to
11.3 ± 7.9 days, P = 0.014), the mean difference in
length of stay was 4.3 days between groups. There were no
other clinical or demographical statistically significant
differences. In univariate analyses serum 25-OH-D level
was inversely correlated with the length of stay in our
orthopaedic department compared to patients with normal
vitamin D levels (r = -0.16; P = 0.008). In multivariate
analysis, after adjusting for age, sex, primary muscu-
loskeletal diagnosis, BMI and comorbidities, the length of
stay remained significantly associated with low 25-OH-D
levels (P = 0.002), indicating that low vitamin D levels
increase the length of stay (Table 2).
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Table 1 Characteristics and








Male (n = 516) 391 125 Reference
Female (n = 567) 290 277 0.138
Age (years), mean ± SD 76.9 75.5 0.51
Main reason for admission
Hip arthroplasty (n = 606) 370 236
Knee arthroplasty (n = 477) 292 185
Comorbidities
Osteoporosis (n = 238) 197 41 0.057
Hypertension (n = 606) 399 207 0.61
Cardiovascular disease (n = 530) 356 174 0.63
Thyreotic Abnormality (n = 465) 299 166 0.87
Pulmonary disease (n = 205) 130 75 0.52
Renal failure (n = 238) 127 111 0.88
Infectious diseases (n = 22) 14 8 0.72
Vitamin D Suppl. (n = 162) 103 59 0.062
Diabetes (n = 509) 244 265 0.89
Obesity (BMI[ 30 kg/m2) (n = 389) 256 133 0.26
Protone pump inhibitors (n = 629) 409 220 0.1
Acetylsalicylic acid (n = 493) 294 199 0.756
Metamizole (n = 328) 200 128 0.19




N-acetyl-p-aminophenol (n = 341) 201 140 0.52
Indomethacin (n = 298) 155 143 0.86
Length of stay (days), mean ± SD 15.6 ± 7.2 11.3 ± 7.9 0.014
Table 2 Multivariate linear
regression analyses for
association between length of
stay and vitamin D deficiency
after adjusting for possible
confounders
Variables Mean difference (95 % CI) Significance (P)
Gender (male) 0.01 (-0.1 to 0.3) 0.37
Age 0.09 (-1.5 to 3.28) 0.52
Primary diagnosis (hip arthroplasty
vs. knee arthroplasty)
0.48 (-2.83 to 4.01) 0.78
Osteoporosis 0.06 (-4.07 to 3.94) 0.97
Hypertension 0.008 (-0-03 to 0.09) 0.81
Cardiovascular disease 0.5 (-1.4 to 2.4) 0.63
Thyreotic abnormality 0.99 (-2.6 to 2.59) 0.47
Pulmonary disease 0.39 (-5.79 to 5.0) 0.87
Renal failure 0.07 (-4.08 to 3.95) 0.74
Infectious diseases 0.49 (-2.25 to 3.25) 0.72
Diabetes 3.76 (-2.1 to 9.68) 0.2
Obesity (BMI[30 kg/m2) 1.26 (-1.42 to 3.95) 0.34
Vitamin D deficiency 4.3 (0.5 to 6.78) 0.002
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Discussion
To the best of our knowledge, this study is the first study to
report a possible association between low vitamin D levels
and length of stay in orthopaedic patients. Vitamin D status
was evaluated in view of its possible role as a predictor of
hospital length of stay. We observed a high prevalence of
vitamin D-deficient states among patients admitted to the
orthopaedic department. Furthermore, a highly significant
inverse correlation between 25-OH-D level and length of
stay was observed.
Lee et al. [10] demonstrated in a longitudinal cohort
study of 191 patients that preoperative hypovitaminosis D
was not associated with worse health-related quality of life
at 3 months postoperatively. But preoperative hypovita-
minosis D had a subtle effect on pain intensity scores in
early postoperative period. Furthermore, low vitamin D
levels were a risk factor for moderate-to-severe persistent
pain after knee arthroplasty. Unnnanuntana et al. [11]
evaluated the association between preoperative serum
vitamin D level and the attainment of in-hospital functional
milestones. Data from 200 patients, scheduled to undergo
total hip arthroplasty, was collected. They found no influ-
ence of vitamin D on the attainment of in-hospital mile-
stones and the length of stay. Low vitamin D levels were
not associated with further perioperative complications.
One recent study evaluated the association between serum
levels of 25-OD-D and handgrip strength, midupper arm
muscle mass and the length of hospital stay after hip
fracture; 102 patients with hip fracture and aged over
65 years of age were enrolled. In the multiple linear
regression analyses, serum 25-OH-D levels were associated
with handgrip strength but not with muscle mass or length
of hospital stay [12].
Vitamin D is a steroid hormone with pleiotropic effects
[13]. Most of the known biological actions are mediated
through binding to the vitamin D receptor present in almost
all tissues and cells within the human body. While its
classical action is that of a regulator of calcium/phosphate
homeostasis and bone metabolism, several studies have
demonstrated that this steroid has further multiple roles.
Thus, vitamin D is not only important to bone health, but
also plays an important role in immunomodulation, regu-
lation of inflammation and cytokines, cell proliferation, cell
differentiation, apoptosis, angiogenesis, muscle strength
and muscle contraction [6, 9, 14]. Since 25-OH-D is
essential for the regulation of cellular growth, differentia-
tion and function, low 25-OH-D levels lead to multiple
organ dysfunction, disability and unstable health, which are
all causes of deconditioning, polypharmacy and longer
length of hospital stay [7, 15, 16]. Several studies revealed
a widespread rate of vitamin D insufficiency and deficiency
in orthopaedic patients [17–20]. In their study of 723
orthopaedic patients, Bogunovic et al. [17] demonstrated a
prevalence of up to 66 % of abnormal (insufficient or
deficient) 25-OH-D levels. Patients of dark skin tone were
identified to be at higher risk of hypovitaminosis D than
those with lighter skin tones. In previous studies, we were
able to show a prevalence of 84 % of vitamin D insuffi-
ciency, and of 60 % of vitamin D insufficiency in 1119
patients of all ages consecutively admitted to an ortho-
paedic university hospital in central Germany. Of note,
only 15 % of tested patients were in the target range of
30–60 ng/mL [18, 19].
In addition, hypovitaminosis D has been proposed as a
new biomarker of longer length of stay in acute care units.
Zittermann et al. [21] showed that lower 25-OH-D levels
were independently associated with a prolonged intensive
care unit stay after cardiac surgery. In further studies, low
vitamin D levels doubled the risk of being in hospital for
more than 14 days in a geriatric acute care unit [22], and
the combination of insufficient 25-OH-D level, male gen-
der and delirium predicted a 4.8-fold higher risk of longer
length of stay among geriatric inpatients [23]. Helard et al.
[7] evaluated 253 geriatric inpatients of an acute geriatric
care unit and showed an inverse linear correlation between
serum 25-OH-D level and the length of stay in the acute
geriatric care unit. Participants with 25-OH-D levels below
50 nmol/L (20 ng/mL) stayed on average 3 days longer in
hospital than those with 25-OH-D above 50 nmol/L. A
1-day decrease in length of stay was seen per 7.1 nmol/L
increase in 25-OH-D. In their study of 259 consecutive
admitted patients to a surgical intensive care unit, Mathews
et al. [6] reported an inverse relationship between vitamin
D level and the length of stay in the surgical intensive care
unit. Furthermore, vitamin D deficiency was correlated
inversely with surgical intensive care unit treatment cost
and mortality. Consistent with these results, we were able
to show an inverse relationship between 25-OH-D level
and the length of stay in our orthopaedic department.
Patients with 25-OH-D below 20 ng/mL stayed on average
4.3 days longer on the ward than patients with vitamin D
levels above 20 ng/mL.
Vitamin D supplementation is safe and simple. The
Endocrine Society’s practice guidelines recommend treat-
ment strategies for patients with low serum vitamin D
levels depending on age and underlying medical condi-
tions. They recommend that vitamin D deficient adults
should be treated with 50,000 IU vitamin D2 or vitamin D3
once a week for 8 weeks, or with *6000 IU/day vitamin
D2 or vitamin D3, followed by maintenance therapy of
1500–2000 IU/day. In obese patients, patients with mal-
absorption syndromes, and patients on medications
affecting vitamin D metabolism, two to three times higher
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doses (at least 6000–10,000 IU/day vitamin D) are rec-
ommended to treat vitamin D deficiency, followed by
maintenance therapy of at least 3000–6000 IU/day [24].
Dawson-Hughes et al. [25] recommended an estimated
average essential vitamin D supplementation of
800–1000 IU/day (20–25 lg/day) in order to reach a serum
25(OH)D level above 75 nmol/L in the elderly. Signifi-
cantly higher dosages are required to ensure that virtually
all elderly people achieve this level of vitamin D. In their
randomised, double-blind, placebo-controlled single centre
trial, Amrein et al. [26] showed that even high-dose oral
vitamin D corrected low vitamin D concentration without
adverse effects. Vitamin D was given orally or via naso-
gastric tube once at a dose of 540,000 IU followed by a
monthly maintenance dose of 90,000 IU. They showed
that, among critically ill patients with vitamin D deficiency,
supplementation of vitamin D did not reduce hospital
length of stay or hospital mortality. But lower hospital
mortality was found in the severe vitamin D deficiency
subgroup, but, according to the authors, this finding should
be considered hypothesis generating.
Nevertheless, potential limitations to our study should
be considered. The majority of the tested patients in this
study had white skin tones. Given the predisposition of
darker skin-toned individuals toward lower 25-OH-D
levels, hypovitaminosis D among darker skin-toned
orthopaedic patients may be underrepresented in this study
[4]. The generalisability of our findings may be limited,
even though we treated a mixed population of adult
orthopaedic patients with no restriction on age, sex, or
admission diagnosis. Furthermore, the geographical local-
isation of Mainz (50 northern latitude) limits our results to
regions around this latitude, e.g. Paris (48510N), Van-
couver (49150N), Calgary (5130N) or Kiev (50270) or
above 50 latitude. Finally, it should be borne in mind that,
in some cases, the length of stay depends not only on
bioclinical aspects but is influenced by other factors, e.g.
human resource employees, insurance guidelines, number
of beds available, etc.
In the present study, we found a high frequency of
hypovitaminosis D among orthopaedic patients scheduled
to undergo elective hip or knee arthroplasty. Low vitamin
D levels showed a significant inverse association to the
length of stay in our orthopaedic department. Patients with
vitamin D levels in the target range were hospitalised
4.3 days less than patients with hypovitaminosis D.
Vitamin D supplementation is safe and simple and may
be a possible way to reduce the length of hospital stay after
hip and knee arthroplasty, but further randomised con-
trolled trials on the pre- and post-operative impact of
vitamin D supplementation may be needed to confirm this
hypothesis.
Compliance with ethical standards
Conflict of interest Each author certifies that he or she, or a member
of his or her immediate family, has no funding or commercial asso-
ciations (e.g. consultancies, stock ownership, equity interest, patent/
licensing arrangements, etc.) that might pose a conflict of interest in
connection with the submitted article.
Ethical standards All procedures performed in studies involving
human participants were in accordance with the ethical standards of
the institutional and/or national research committee, and with the
1964 Helsinki declaration and its later amendments or comparable
ethical standards.
Informed consent Informed consent was obtained from all indi-
vidual participants included in the study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes
B, Eisman JA et al (2009) Global vitamin D status and deter-
minants of hypovitaminosis D. Osteoporos Int 20:1807–1820
2. Holick MF (1995) Environmental factors that influence the cuta-
neous production of vitamin D. Am J Clin Nutr 61:638S–645S
3. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K (2005)
Association between 25-hydroxy vitamin D levels, physical
activity, muscle strength and fractures in the prospective popu-
lation-based OPRA study of elderly women. Osteoporos Int
16:1425–1431
4. Maier GS, Horas K, Seeger JB, Roth KE, Kurth AA, Maus U
(2015) Vitamin D insufficiency in the elderly orthopaedic patient:
an epidemic phenomenon. Int Orthop 39:787–792
5. LeBoff MS, Hawkes WG, Glowacki J, Yu-Yahiro J, Hurwitz S,
Magaziner J (2008) Vitamin D-deficiency and post-fracture
changes in lower extremity function and falls in women with hip
fractures. Osteoporos Int 19:1283–1290
6. Matthews LR, Ahmed Y, Wilson KL, Griggs DD, Danner OK
(2012) Worsening severity of vitamin D deficiency is associated
with increased length of stay, surgical intensive care unit cost,
and mortality rate in surgical intensive care unit patients. Am J
Surg 204:37–43
7. Helard L, Mateus-Hamdan L, Beauchet O, Annweiler C (2013)
Hypovitaminosis D in geriatric acute care unit: a biomarker of
longer length of stay. Dis Markers 35:525–529
8. World Health Organization (2003) Prevention and management
of osteoporosis: report of a WHO scientific group. World Health
Organization, Geneva
9. Holick MF (2007) Vitamin D deficiency. N Engl J Med
357:266–281
10. Lee A, Chan S, Samy W, Chiu C, Gin T (2015) Effect of
hypovitaminosis D on postoperative pain oustcomes and short-
term health-related quality of life after knee arthroplasty. Medi-
cine (Baltimore) 94:e1812
11. Unnanuntana A, Rebolledo BJ, Gladnick BP et al (2012) Does
vitamin D status affect the attainment of in-hospital functional
J Orthopaed Traumatol (2016) 17:297–302 301
123
milestones after total hip arthroplasty? J Arthroplast 27:482–489.
doi:10.1016/j.arth.2011.05.023
12. Gumieiro DN, Murino Rafacho BP, Buzati Pereira BL et al
(2001) Vitamin D serum levels are associated with handgrip
strength but not with muscle mass or length of hospital stay after
hip fracture. Nutrition 31:1–4
13. Hamada Y, Fukagawa M (2007) The pleiotropic effects of vita-
min D on kidney disease. Clin Calcium 17:712–717
14. Maier GS, Horas K, Seeger JB, Roth KE, Kurth AA, Maus U
(2014) Is there an association between periprosthetic joint
infection and low vitamin D levels? Int Orthop 38:1499–1504
15. Subramaniam C, Gray LC, Farish S (1995) Predictors of length of
stay in a geriatric assessment and rehabilitation unit. Aust Health
Rev 18:56–68
16. Zanocchi M, Maero B, Maina P, Ponzetto M, Francisetti F, Giona
E et al (2002) Factors predicting a prolonged hospital stay in
elderly patients. Minerva Med 93:135–143
17. Bogunovic L, Kim AD, Beamer BS, Nguyen J, Lane JM (2010)
Hypovitaminosis D in patients scheduled to undergo orthopaedic
surgery: a single-center analysis. J Bone Jt Surg Am
92:2300–2304
18. Maier GS, Jakob P, Horas K, Roth KE, Kurth AA, Maus U (2013)
Vitamin D deficiency in orthopaedic patients: a single center
analysis. Acta Orthop Belg 79:587–591
19. Maier GS, Jakobs P, Roth KE, Kurth AA, Maus U (2013) Is there
an epidemic vitamin D deficiency in german orthopaedic
patients? Clin Orthop Relat Res 471:3029–3035
20. Maier GS, Seeger JB, Horas K, Roth KE, Kurth AA, Maus U
(2015) The prevalence of vitamin D deficiency in patients with
vertebral fragility fractures. Bone Jt J 97-B:89–93
21. Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Borg-
ermann J (2013) Vitamin D status and the risk of major adverse
cardiac and cerebrovascular events in cardiac surgery. Eur Heart J
34:1358–1364
22. Beauchet O, Launay CP, Maunoury F, de Decker L, Fantino B,
Annweiler C (2013) Association between vitamin D deficiency
and long hospital stay in geriatric acute care unit: results from a
pilot cohort study. Aging Clin Exp Res 25:107–109
23. Beauchet O, Launay C, de Decker L, Fantino B, Kabeshova A,
Annweiler C (2013) Who is at risk of long hospital stay among
patients admitted to geriatric acute care unit? Results from a
prospective cohort study. J Nutr Health Aging 17:695–699
24. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM,
Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine
Society (2011) Evaluation, treatment, and prevention of vitamin
D deficiency: an endocrine society clinical practice guideline.
J Clin Endocrinol Metab 96:1911–1930
25. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt
P, Fuleihan GE et al (2010) IOF position statement: vitamin D
recommendations for older adults. Osteoporos Int 21:1151–1154
26. Amrein K, Schnedl C, Holl A et al (2014) Effect of high-dose
vitamin D3 on hospital length of stay in critically ill patients with
vitamin D deficiency: the VITdAL-ICU randomized clinical trial.
JAMA 312:1520–1530. doi:10.1001/jama.2014.13204
302 J Orthopaed Traumatol (2016) 17:297–302
123
